Health
The topics this product tracks, the most attention first. Attention is measured against each topic’s own history — 50 is its usual level — so a high figure means unusually busy for that topic, not the most-discussed topic in the world.
Ordered by each topic’s current Attention figure: 0–100 against that topic’s own recent history, with 50 its usual level. Topics with no figure yet are listed last, A–Z. How attention is measured.
- Tuberculosis45Attentionabout usual · +1.4 ptsup over 24 hoursTB cases, drug-resistant TB and TB vaccines.
- AI in healthcare45Attentionabout usual · +2.3 ptsup over 24 hoursAI models in diagnosis, radiology, clinical work and drug discovery.
- Pharmaceutical industry45Attentionbelow usual · +5.1 ptsup over 24 hoursThe large drugmakers — Pfizer, Eli Lilly, Novo Nordisk, AstraZeneca, Merck and peers.
- US health department (HHS)44Attentionbelow usual · −2.0 ptsdown over 24 hoursThe Department of Health and Human Services, its secretary, and the agencies under it.
- Obesity and metabolic drugs44Attentionbelow usual · −17.3 ptsdown over 24 hours
- Drug approvals and trials41Attentionbelow usual · −4.9 ptsdown over 24 hours
- Biotechnology and genomics40Attentionbelow usual
- Vaccination37Attentionbelow usual · +1.9 ptsup over 24 hours
- Mental health36Attentionbelow usual · −26.6 ptsdown over 24 hours
- Epidemics and pandemic risk33Attentionbelow usual · −9.0 ptsdown over 24 hours
- HIV and AIDS32Attentionbelow usual · ±0.0 ptsunchanged over 24 hoursHIV prevention, treatment and the funding behind it.